In draft guidance published today for consultation, NICE has recommended rivaroxaban (Xarelto, Bayer Healthcare) as an option for preventing blood clots in people who have had a heart attack as a ...

This guideline covers the early and longer-term (rehabilitation) management of acute coronary syndromes. These include ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation ...

Discussion/Follow-up Care For patients with COVID-19 and STEMI, percutaneous coronary intervention remains the treatment of choice. For patients with COVID-19 and NSTEMI, conservative therapy is ...

The acute coronary syndromes include unstable angina, non-ST segment elevation myocardial infarction and ST segment elevation myocardial infarction. The terms “transmural,” “non-transmural,” “Q wave ...

Introduction: Recently, interest has been growing in lipoprotein(a) (Lp[a]) as an independent risk factor for cardiovascular diseases. European Society of Cardiology recommends a single measurement of ...

People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...